Glycosylation-independent binding to extracellular domains 11-13 of mannose-6-phosphate/insulin-like growth factor-2 receptor mediates the effects of soluble CREG on the phenotypic modulation of vascular smooth muscle cells.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Molecular and Cellular Cardiology

• Publication date

  2011-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.yjmcc.2010.12.013PMID 21195083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CREG inhibits migration of human vascular smooth muscle cells by mediating IGF-II endocytosis.

  2009cited by this paper
• CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery.

  2008cited by this paper
• Secreted CREG inhibits cell proliferation mediated by mannose 6‐phosphate/insulin‐like growth factor II receptor in NIH3T3 fibroblasts

  2008cited by this paper
• Adenovirus-mediated intra-arterial delivery of cellular repressor of E1A-stimulated genes inhibits neointima formation in rabbits after balloon injury.

  2008cited by this paper
• Cell Surface-expressed Cation-independent Mannose 6-Phosphate Receptor (CD222) Binds Enzymatically Active Heparanase Independently of Mannose 6-Phosphate to Promote Extracellular Matrix Degradation*

  2008cited by this paper
• Cellular repressor of E1A-stimulated genes is a bona fide lysosomal protein which undergoes proteolytic maturation during its biosynthesis.

  2008cited by this paper
• Proteomics Analysis of Serum from Mutant Mice Reveals Lysosomal Proteins Selectively Transported by Each of the Two Mannose 6-Phosphate Receptors*S

  2008cited by this paper
• Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells.

  2007cited by this paper
• Wilms’ Tumor 1–Associating Protein Regulates the Proliferation of Vascular Smooth Muscle Cells

  2006cited by this paper
• The crystal structure of CREG, a secreted glycoprotein involved in cellular growth and differentiation.

  2005influential reference
• [Expression of cellular repressor of E1A-stimulated genes in vascular smooth muscle cells of different phenotypes].

  2005cited by this paper
• Identification of a Low Affinity Mannose 6-Phosphate-binding Site in Domain 5 of the Cation-independent Mannose 6-Phosphate Receptor*

  2004cited by this paper
• The secreted glycoprotein CREG inhibits cell growth dependent on the mannose-6-phosphate/insulin-like growth factor II receptor

  2003influential reference
• Mannose 6-phosphate receptors: new twists in the tale

  2003cited by this paper
• Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation

  2002cited by this paper
• Towards a human repertoire of monocytic lysosomal proteins

  2000cited by this paper
• The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cells

  2000cited by this paper
• Recognition of Dictyostelium discoideum lysosomal enzymes is conferred by the amino-terminal carbohydrate binding site of the insulin-like growth factor II/mannose 6-phosphate receptor.

  2000cited by this paper
• A Cellular Repressor of E1A-Stimulated Genes That Inhibits Activation by E2F

  1998cited by this paper
• Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors.

  1992cited by this paper
• Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor.

  1991cited by this paper
• The bovine mannose 6-phosphate/insulin-like growth factor II receptor. Localization of mannose 6-phosphate binding sites to domains 1-3 and 7-11 of the extracytoplasmic region.

  1991cited by this paper
• Ligand interactions of the cation-independent mannose 6-phosphate receptor. The stoichiometry of mannose 6-phosphate binding.

  1989cited by this paper

• CREG1 promotes bone formation via targeting RAB7 to activate autophagy in osteoporosis.

  2026cites this paper
• A novel function of CREG in metabolic disorders

  2021cites this paper
• CREG ameliorates the phenotypic switching of cardiac fibroblasts after myocardial infarction via modulation of CDC42

  2021cites this paper
• The secreted inhibitor of invasive cell growth CREG1 is negatively regulated by cathepsin proteases

  2020cites this paper
• PAPP-A and the IGF system in Atherosclerosis - What's Up, What's Down?

  2019cites this paper
• Proximity proteomics in a marine diatom reveals a putative cell surface-to-chloroplast iron trafficking pathway

  2019cites this paper
• CREG1: Its Role as a Master Regulator of Liver Function

  2019cites this paper
• Antiapoptotic role of the cellular repressor of E1A-stimulated genes (CREG) in retinal photoreceptor cells in a rat model of light-induced retinal injury.

  2018cites this paper
• The Structure and Biological Function of CREG

  2018cites this paper
• Cellular Repressor of E1A-Stimulated Genes Is a Critical Determinant of Vascular Remodeling in Response to Angiotensin II

  2017cites this paper
• Cellular Repressor of E1A-stimulated Genes, A New Potential Therapeutic Target for Atherosclerosis.

  2017cites this paper
• Exploitation of the Ligand-Binding Properties of the Mannose 6-Phosphate/Insulin-Like Growth Factor II (IGF-II) Receptor to Inhibit IGF-II-Dependent Growth of Cancer Cells

  2016cites this paper
• Soluble M6P/IGFIIR in the circulation.

  2015cites this paper
• Drosophila melanogaster cellular repressor of E1A-stimulated genes is a lysosomal protein essential for fly development

  2014cites this paper
• Nanoporous CREG-Eluting Stent Attenuates In-Stent Neointimal Formation in Porcine Coronary Arteries

  2013cites this paper
• MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes.

  2013cites this paper
• Dominant‐negative effect of truncated mannose 6‐phosphate/insulin‐like growth factor II receptor species in cancer

  2012cites this paper
• CREG mediated adventitial fibroblast phenotype modulation: a possible therapeutic target for proliferative vascular disease.

  2012cites this paper
• Cellular repressor E1A-stimulated genes controls phenotypic switching of adventitial fibroblasts by blocking p38MAPK activation.

  2012cites this paper
• CREG: a possible candidate for both prevention and treatment of proliferative vascular disease.

  2012cites this paper
• Overexpression of CREG attenuates atherosclerotic endothelium apoptosis via VEGF/PI3K/AKT pathway.

  2011cites this paper